To further proof that targeting CHI3L1 by nCHI3L1 Abs resulted in decrease of CHI3L1 expression to elicit an immune-stimulatory TME, multi-color IF-IHC was performed on the LLC tumor sections. This evidence concerns the gene CHI3L1 and neoplasm.